Canaccord Genuity Group Has Lowered Expectations for Bioceres Crop Solutions (NASDAQ:BIOX) Stock Price

Bioceres Crop Solutions (NASDAQ:BIOX) had its target price reduced by Canaccord Genuity Group from $9.50 to $7.00 in a research report released on Friday,Benzinga reports. They currently have a buy rating on the stock.

Separately, Oppenheimer decreased their price target on shares of Bioceres Crop Solutions from $13.00 to $12.00 and set an “outperform” rating for the company in a research report on Tuesday, January 28th. Four analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Buy” and an average target price of $10.00.

Bioceres Crop Solutions Trading Down 0.5 %

NASDAQ:BIOX opened at $5.55 on Friday. The firm has a 50-day simple moving average of $6.65 and a 200-day simple moving average of $7.86. Bioceres Crop Solutions has a one year low of $5.50 and a one year high of $14.05. The firm has a market cap of $348.04 million, a P/E ratio of 277.64 and a beta of 0.57. The company has a debt-to-equity ratio of 0.37, a quick ratio of 0.87 and a current ratio of 1.27.

Bioceres Crop Solutions (NASDAQ:BIOX) last announced its earnings results on Monday, November 11th. The company reported ($0.09) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.02 by ($0.11). The company had revenue of $92.60 million for the quarter, compared to the consensus estimate of $117.15 million. Bioceres Crop Solutions had a net margin of 0.53% and a return on equity of 0.68%. During the same period last year, the business posted ($0.07) EPS. Equities analysts anticipate that Bioceres Crop Solutions will post 0.12 EPS for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. Ping Capital Management Inc. raised its position in shares of Bioceres Crop Solutions by 7.3% in the 4th quarter. Ping Capital Management Inc. now owns 44,000 shares of the company’s stock valued at $268,000 after purchasing an additional 3,000 shares during the last quarter. Stifel Financial Corp raised its holdings in shares of Bioceres Crop Solutions by 33.4% in the third quarter. Stifel Financial Corp now owns 40,790 shares of the company’s stock worth $321,000 after buying an additional 10,224 shares during the last quarter. Dimensional Fund Advisors LP lifted its stake in shares of Bioceres Crop Solutions by 9.5% during the second quarter. Dimensional Fund Advisors LP now owns 61,330 shares of the company’s stock worth $688,000 after buying an additional 5,341 shares during the period. JPMorgan Chase & Co. grew its holdings in shares of Bioceres Crop Solutions by 49.3% during the third quarter. JPMorgan Chase & Co. now owns 89,973 shares of the company’s stock valued at $708,000 after buying an additional 29,693 shares during the last quarter. Finally, Fourth Sail Capital LP grew its holdings in shares of Bioceres Crop Solutions by 16.6% during the fourth quarter. Fourth Sail Capital LP now owns 3,698,961 shares of the company’s stock valued at $22,490,000 after buying an additional 527,859 shares during the last quarter. 17.68% of the stock is owned by institutional investors and hedge funds.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.